iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
1,934.8
(-1.75%)
Feb 6, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
1,1250%₹331.3 0%1,640--
3750%₹281.95 0%1,680₹3.25 4.83%18,7500%
3,0000%₹172 0%1,700--
1,1250%₹238.55 0%1,720₹4.3 11.68%64,500-19.62%
--1,740₹5.45 14.73%25,500-30.61%
--1,760₹7.1 18.33%22,875-12.85%
4,1250%₹194.55 0%1,780₹9.1 32.84%33,375-16.03%
10,50012%₹140.2 -11.37%1,800₹11.55 32%1,14,750-13.06%
6,0006.66%₹131.95 -4.59%1,820₹14.75 27.15%55,87563.73%
7,5000%₹123.75 0%1,840₹18.6 11.71%26,25037.25%
23,2500%₹103.85 -18.51%1,860₹22.95 27.5%46,875-13.19%
21,7500%₹89.85 -19.95%1,880₹28.5 39.02%50,625-2.17%
54,750-39.16%₹74.75 -25.39%1,900₹35.1 27.86%2,13,375-1.21%
41,250-62.71%₹63.05 -26.6%1,920₹42.8 29.3%78,0003.48%
86,62592.5%₹52 -29.01%1,940₹51.25 25.76%68,25013.04%
1,72,87521.95%₹42.2 -32.2%1,960₹62.05 29.67%2,35,125-0.31%
1,14,375-2.24%₹34.35 -34.88%1,980₹73.45 24.8%70,125-0.53%
3,71,2505.43%₹27.2 -37.39%2,000₹85.4 21.04%93,750-4.21%
96,000-3.39%₹21.5 -37.95%2,020₹88.85 2.36%33,3750%
1,35,00048.14%₹16.95 -41.24%2,040₹97.65 0%14,2500%
1,27,1254.62%₹13.45 -39.27%2,060₹145.25 33.62%1,07,6250.34%
2,48,62511.24%₹10.75 -39.77%2,080₹141.1 0%7,8750%
3,99,3754.10%₹8.4 -42.46%2,100₹137.55 0%19,1250%
49,125-3.67%₹6.5 -43.96%2,120₹164.05 0%13,1250%
6,37513.33%₹5.45 -38.41%2,140₹174.3 0%3,0000%
56,250-1.31%₹4.15 -42.75%2,160₹182.15 0%2,2500%
3750%₹47 0%2,180--
1,50,3752.29%₹2.9 -38.94%2,200₹196.85 0%7,5000%
25,500-10.52%₹2.65 -36.14%2,220₹240 0%3750%
23,2500%₹2.55 0%2,240₹258 0%3,3750%
7500%₹6.65 0%2,260--
18,750-13.79%₹1.6 -20%2,280--
6,000-42.85%₹1.6 -20%2,300₹310 0%38,2500%
60,000-1.84%₹1.3 -25.71%2,320--
20,250-1.81%₹1 -39.39%2,360--
30,000-2.43%₹0.6 -40%2,400--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.